You are here

FDA to Evaluate Homeopathic Product Regulatory Framework

April 2, 2015

As many in the homeopathic community already know, the FDA recently announced that it will hold a public hearing to obtain information and comments from stakeholders about the current use of human drug and biological products labeled as homeopathic, as well as the Agency’s regulatory framework for such products. This hearing will take place on April 20 and 21, 2015 in the Washington, DC area. NCH is currently working with experts across the homeopathic community, such as from the manufacturing industry, advocacy groups, and professional organizations, to present a strategic, unified response. NCH will have representation at this hearing.

We will provide the NCH community with additional updates about this process as information becomes available. Individual action from community members is not required at the time. Should a time come when action from individuals in the community is needed, we will communicate details about how to get involved at that time.

View the Federal Register Notice for more details about topics to be addressed at the hearing. 

If you would like to receive updates about this topic, please make sure you are registered for our free e-newsletter. If you already receive the newsletter, you will already be included in our update distribution list.

And consider joining or renewing your membership with NCH. The greater our numbers united, the stronger our response will be in Washington!